Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Haba Laboratories stock price, quote, forecast and news

4925.T
JP3765130004

Price

1,988.00
Today +/-
-0.04
Today %
-0.35 %
P

Haba Laboratories stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Haba Laboratories stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Haba Laboratories stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Haba Laboratories stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Haba Laboratories's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Haba Laboratories Stock Price History

DateHaba Laboratories Price
9/11/20241,988.00 undefined
9/10/20241,995.00 undefined
9/9/20241,989.00 undefined
9/6/20241,993.00 undefined
9/5/20241,994.00 undefined
9/4/20241,998.00 undefined
9/3/20242,000.00 undefined
9/2/20242,000.00 undefined
8/30/20241,994.00 undefined
8/29/20241,999.00 undefined
8/28/20242,000.00 undefined
8/27/20241,994.00 undefined
8/26/20241,990.00 undefined
8/23/20241,968.00 undefined
8/22/20241,954.00 undefined
8/21/20241,952.00 undefined
8/20/20241,950.00 undefined
8/19/20241,935.00 undefined
8/16/20241,940.00 undefined
8/15/20241,945.00 undefined
8/14/20241,964.00 undefined

Haba Laboratories Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Haba Laboratories, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Haba Laboratories from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Haba Laboratories’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Haba Laboratories. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Haba Laboratories’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Haba Laboratories’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Haba Laboratories’s growth potential.

Haba Laboratories Revenue, EBIT and net profit per share

DateHaba Laboratories RevenueHaba Laboratories EBITHaba Laboratories Net Income
202412.32 B undefined-187.77 M undefined-2.12 B undefined
202312.04 B undefined-609.64 M undefined-707.87 M undefined
202212.91 B undefined-316.73 M undefined-269.03 M undefined
202114.31 B undefined226.97 M undefined216.42 M undefined
202018.37 B undefined2 B undefined1.31 B undefined
201919.25 B undefined3.1 B undefined2.09 B undefined
201817.89 B undefined2.4 B undefined1.6 B undefined
201716.14 B undefined1.77 B undefined1.21 B undefined
201614.81 B undefined1.53 B undefined982.4 M undefined
201513.18 B undefined282.85 M undefined44.83 M undefined
201413.79 B undefined1.25 B undefined916 M undefined
201313.23 B undefined428 M undefined10 M undefined
201213.58 B undefined1.04 B undefined538 M undefined
201111.81 B undefined580 M undefined22 M undefined
201011.32 B undefined892 M undefined266 M undefined
200911.18 B undefined867 M undefined393 M undefined
200811.04 B undefined663 M undefined300 M undefined
200711.03 B undefined1.14 B undefined611 M undefined
200610.78 B undefined1.02 B undefined372 M undefined
200510.08 B undefined1.19 B undefined623 M undefined

Haba Laboratories Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
7.38.129.8410.0810.7811.0311.0411.1811.3211.8113.5813.2313.7913.1814.8116.1417.8919.2518.3714.3112.9112.0412.32
-11.1221.272.446.902.330.131.271.214.3514.98-2.544.18-4.4012.378.9410.857.65-4.59-22.11-9.78-6.742.38
80.6481.2781.7181.5280.8580.0478.0578.1779.7980.8474.7374.2775.9975.6875.5075.0774.5875.3874.3971.2968.1367.8568.18
5.896.68.048.228.718.838.628.749.039.5510.159.8310.489.9811.1812.1113.3414.5113.6610.28.798.178.4
0.480.831.21.191.021.140.660.870.890.581.040.431.250.281.531.772.43.120.23-0.32-0.61-0.19
6.5910.1812.1411.769.4710.356.007.757.884.917.623.239.102.1410.3010.9613.4216.0810.871.58-2.45-5.06-1.52
0.340.350.580.620.370.610.30.390.270.020.540.010.920.040.981.211.62.091.310.22-0.27-0.71-2.12
-2.0466.007.23-40.2964.25-50.9031.00-32.32-91.732,345.45-98.149,060.00-95.202,131.8223.5231.6630.75-37.12-83.55-224.54162.83199.58
-----------------------
-----------------------
22444434444443.933.933.933.933.933.873.783.783.783.78
-----------------------
Details

Keystats

ⓘ

Revenue and Growth

The Haba Laboratories Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Haba Laboratories is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (M)INVENTORIES (B)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (B)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                             
1.552.022.552.773.173.392.483.463.663.183.613.373.573.763.833.725.045.925.235.665.654.823.96
0.690.80.930.920.870.981.031.031.031.051.561.641.951.721.951.621.891.971.421.21.130.981.26
00000000000000000000000
0.550.740.750.881.131.11.191.351.511.711.911.91.561.871.892.412.292.94.264.033.153.373.71
297144258246351301326311330500683301338566.93270.55379.01145.48128.56238.88415.13143.45182.39145.77
3.093.74.484.825.525.785.026.156.526.447.767.227.427.927.948.139.3710.9211.1511.3110.079.349.08
1.11.222.192.352.533.814.694.484.965.075.494.935.374.374.274.444.694.464.7154.664.452.96
31273891951146755393097711.455.256.676.615.024.035.316.457.0511.86
00000000000000000000000
2202562822601881881431127874131284257234.55308.84678.19774.08696.78758.09522.3346.18315.770
1459364181385849284510948684421023.4400000000
671522515522502459506582480521390524489431.21236.14255.43396.4415.62469.58596.72605.51536.34386.9
2.172.113.093.243.334.585.465.275.846.216.976.436.545.044.855.385.875.575.946.135.615.313.35
5.265.827.578.068.8610.3510.4811.4312.3612.6414.7313.6513.9612.9612.7913.5115.2416.4917.0917.4415.6914.6612.43
                                             
218278500500500500696696696696696696696696.45696.45696.45696.45696.45696.45696.45696.45696.45696.45
173235613613613617813813813813813813813812.57812.57812.57812.57812.57812.57812.57812.57812.57812.57
0.781.111.642.212.523.073.313.633.823.764.224.154.994.955.866.998.4710.4411.611.6611.2610.48.13
000035312000145.124.433.764.372.982.372.635.3100
-1-1441180-2-2-40111.5301.361.330.47-0.220.671.461.885.22
1.171.622.763.323.654.24.825.155.325.265.735.666.56.477.378.519.9911.9513.1113.1712.7711.919.64
211371332290475475317285323366823870537623.71401347.68347.6494.34474.39310.26336.16475.69303.01
11911213212510813212315816713863598672.75129.7616.81119.1178.4810.6983.7492.1126.629.87
0.620.641.070.730.951.210.961.110.821.181.161.571.871.281.521.722.221.851.651.051.021.31.13
2.242.262.182.152.551.541.562.262.632.243.022.031.951.851.050.70.70.60.51.10.30.20.6
253153201294284588696515558818860845755918.34798.57797.51736.81648.91763.11905.98785.04801.09754.72
3.443.533.913.594.363.943.664.334.54.745.935.385.24.743.893.584.133.683.43.452.532.82.81
0.40.380.660.890.671.991.681.572.282.422.652.362.221.921.451.341.090.831.681.911.471.031
0000000000000040.8256.4700000050.92
2572802272281762002512532242004232543333.833.8331.7437.0437.2640.9335.6543.1651.4159.12
0.650.660.891.120.852.191.931.832.512.623.082.612.261.951.531.431.130.871.721.951.521.081.11
4.094.194.84.715.216.135.586.1577.3597.997.466.75.425.015.264.545.125.44.053.883.92
5.275.817.568.038.8610.3310.4111.312.3312.6214.7313.6513.9613.1612.7913.5115.2416.518.2318.5816.8215.7913.57
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Haba Laboratories provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Haba Laboratories's financial health and stability.

Assets

Haba Laboratories's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Haba Laboratories must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Haba Laboratories after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Haba Laboratories's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (B)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (B)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0.580.81.131.090.771.070.610.80.640.450.910.171.640.241.671.742.383.071.930.28-0.27-0.55
207215276323303302442478449456630622633584616537616616630669708559
0000000000000000000000
-0.21-0.35-0.52-0.77-0.48-0.2-0.9-0.41-0.99-0.68-0.860.5-0.69-1.08-0.32-0.8-0.36-1.73-1.98-0.391.250.04
-1868547591931181201042571861228-4774-551034-3899-23263
555349554850786786727673655338261886665
0.070.150.250.670.410.370.410.170.540.360.88-0.10.171.01-0.160.610.580.841.150.42-0.15-0.01
0.40.750.940.710.791.290.270.980.360.410.681.521.54-0.181.911.52.671.920.680.531.710.06
-225-273-1,124-545-371-1,565-1,163-296-882-516-563-299-902-228-768-1,030-890-472-909-881-187-288
-198-280-1,163-686-482-1,831-1,056-351-1,353-732-179-482-959686-363-961-923-471-920-925-216-214
27-6-39-140-111-265106-55-470-216384-183-5791540468-331-10-43-2874
0000000000000000000000
-0.3-0.10.210.270.140.6-0.260.421.12-00.15-1.3-0.31-0.24-1.39-0.46-0.31-0.450.870.98-1.36-0.53
012058100039200000000000-1,156000
-0.3300.740.210.080.540.080.341.04-0.080.07-1.38-0.39-0.32-1.47-0.54-0.43-0.57-0.450.83-1.51-0.68
-----------2.00-2.00-1.00-1.00-1.00-------
-22-22-51-58-59-58-58-78-78-78-78-78-78-78-78-78-117-118-157-151-151-151
-0.130.470.510.230.390.01-0.710.970.05-0.40.57-0.340.20.190.07-0.011.320.88-0.690.44-0.01-0.83
169.3477.9-187.8160.3417.9-273.8-890.8679.1-519.9-104.9118.71,222.6637.3-407.211,139.04464.621,780.561,448.97-234.47-346.951,526.94-232.69
0000000000000000000000

Haba Laboratories stock margins

The Haba Laboratories margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Haba Laboratories. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Haba Laboratories.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Haba Laboratories's sales revenue. A higher gross margin percentage indicates that the Haba Laboratories retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Haba Laboratories's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Haba Laboratories's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Haba Laboratories's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Haba Laboratories. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Haba Laboratories's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Haba Laboratories Margin History

Haba Laboratories Gross marginHaba Laboratories Profit marginHaba Laboratories EBIT marginHaba Laboratories Profit margin
202468.19 %-1.52 %-17.19 %
202367.86 %-5.06 %-5.88 %
202268.13 %-2.45 %-2.08 %
202171.29 %1.59 %1.51 %
202074.38 %10.88 %7.15 %
201975.38 %16.08 %10.85 %
201874.58 %13.42 %8.93 %
201775.07 %10.97 %7.52 %
201675.5 %10.3 %6.63 %
201575.68 %2.15 %0.34 %
201475.99 %9.1 %6.64 %
201374.27 %3.23 %0.08 %
201274.73 %7.62 %3.96 %
201180.84 %4.91 %0.19 %
201079.79 %7.88 %2.35 %
200978.17 %7.75 %3.51 %
200878.05 %6 %2.72 %
200780.04 %10.35 %5.54 %
200680.85 %9.47 %3.45 %
200581.52 %11.76 %6.18 %

Haba Laboratories Stock Sales Revenue, EBIT, Earnings per Share

The Haba Laboratories earnings per share therefore indicates how much revenue Haba Laboratories has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Haba Laboratories earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Haba Laboratories's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Haba Laboratories’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Haba Laboratories's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Haba Laboratories Revenue, EBIT and net profit per share

DateHaba Laboratories Sales per ShareHaba Laboratories EBIT per shareHaba Laboratories Earnings per Share
20243,259.06 undefined-49.65 undefined-560.26 undefined
20233,183.39 undefined-161.22 undefined-187.19 undefined
20223,413.65 undefined-83.76 undefined-71.14 undefined
20213,783.54 undefined60.02 undefined57.23 undefined
20204,746.13 undefined516.19 undefined339.36 undefined
20194,894.65 undefined786.82 undefined530.93 undefined
20184,546.85 undefined610.19 undefined406.2 undefined
20174,101.91 undefined449.87 undefined308.52 undefined
20163,765.16 undefined387.75 undefined249.74 undefined
20153,350.81 undefined71.9 undefined11.4 undefined
20143,446.75 undefined313.5 undefined229 undefined
20133,308.5 undefined107 undefined2.5 undefined
20123,394.75 undefined258.75 undefined134.5 undefined
20112,952.5 undefined145 undefined5.5 undefined
20102,829.5 undefined223 undefined66.5 undefined
20092,795.75 undefined216.75 undefined98.25 undefined
20083,681 undefined221 undefined100 undefined
20072,757.25 undefined285.25 undefined152.75 undefined
20062,694.5 undefined255.25 undefined93 undefined
20052,520.5 undefined296.5 undefined155.75 undefined

Haba Laboratories business model

Haba Laboratories is one of the most popular companies on Eulerpool.com.

Haba Laboratories Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Haba Laboratories historical P/E ratio, EBIT, and P/S ratio.

Haba Laboratories shares outstanding

The number of shares was Haba Laboratories in 2023 — This indicates how many shares 3.782 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Haba Laboratories earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Haba Laboratories's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Haba Laboratories’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Haba Laboratories's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Haba Laboratories dividend history and estimates

In 2023, Haba Laboratories paid a dividend amounting to 40 JPY. Dividend means that Haba Laboratories distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Haba Laboratories provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Haba Laboratories’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Haba Laboratories's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Haba Laboratories Dividend History

DateHaba Laboratories Dividend
202440 undefined
202340 undefined
202240 undefined
202140 undefined
202040 undefined
201940 undefined
201830 undefined
201730 undefined
201620 undefined
201520 undefined
201420 undefined
201320 undefined
201220 undefined
201120 undefined
201020 undefined
200920 undefined
200820 undefined
200720 undefined
200620 undefined
200520 undefined

Haba Laboratories dividend payout ratio

In 2023, Haba Laboratories had a payout ratio of 29.74%. The payout ratio indicates the percentage of the company's profits that Haba Laboratories distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Haba Laboratories represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Haba Laboratories could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Haba Laboratories's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Haba Laboratories Payout Ratio History

DateHaba Laboratories Payout ratio
202437.14 %
202329.74 %
2022-56.22 %
202169.89 %
202011.79 %
20197.53 %
20187.39 %
20179.72 %
20168.01 %
2015175.48 %
20148.73 %
2013800 %
201214.87 %
2011363.64 %
201030.08 %
200920.36 %
200820 %
200713.09 %
200621.51 %
200512.84 %
Unfortunately, there are currently no price targets and forecasts available for Haba Laboratories.

Haba Laboratories list of shareholders

%
Name
Stocks
Change
Date
35.27683 % Koyanagi Public Foundation1,334,00009/30/2023
2.93533 % Koyanagi (Toko)111,000-16,0009/30/2023
1.61311 % Koyanagi (Kazue)61,00009/30/2023
0.60822 % Morgan Stanley & Co. International Plc23,00009/30/2023
0.55533 % Koyanagi (Noriko)21,00009/30/2023
0.52889 % Umeda (Tsunekazu)20,00009/30/2023
0.39667 % Koyanagi (Kumiko)15,00009/30/2023
0.39667 % Meiji Yasuda Life Insurance Company15,00009/30/2023
0.39667 % Dimensional Fund Advisors, L.P.15,000-11,5009/30/2023
0.37022 % Haba Laboratories, Inc. Employees14,00014,0009/30/2023
1
2

Haba Laboratories Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Odakyu Electric Railway Stock
Odakyu Electric Railway
SupplierCustomer0,690,620,220,820,970,78
Kintetsu Group Holdings Stock
Kintetsu Group Holdings
SupplierCustomer0,68-0,57-0,30-0,300,760,83
Seven & I Holdings Stock
Seven & I Holdings
SupplierCustomer0,330,27-0,09-0,78-0,60-0,74
J. FRONT RETAILING Stock
J. FRONT RETAILING
SupplierCustomer0,330,440,280,260,30-0,34
Isetan Mitsukoshi Hldgs Stock
Isetan Mitsukoshi Hldgs
SupplierCustomer0,100,04-0,16-0,68-0,70-0,68
SAN-A Stock
SAN-A
SupplierCustomer-0,330,470,400,490,360,45
1

Most common questions regarding Haba Laboratories

What is the P/E ratio of Haba Laboratories 2024?

The Haba Laboratories P/E ratio is -3.55.

What is the P/S ratio of Haba Laboratories 2024?

The Haba Laboratories P/S ratio is 0.61.

What is the AlleAktien quality score of Haba Laboratories?

The AlleAktien quality score for Haba Laboratories is 1/10.

What is the revenue of Haba Laboratories 2024?

The Haba Laboratories revenue is 12.32 B JPY.

How high is the profit of Haba Laboratories 2024?

The Haba Laboratories profit is -2.12 B JPY.

What is the business model of Haba Laboratories

No history available for Haba Laboratories.

What is the Haba Laboratories dividend?

Haba Laboratories pays a dividend of 40 JPY distributed over payouts per year.

How often does Haba Laboratories pay dividends?

The dividend cannot currently be calculated for Haba Laboratories or the company does not pay out a dividend.

What is the Haba Laboratories ISIN?

The ISIN of Haba Laboratories is JP3765130004.

What is the Haba Laboratories ticker?

The ticker of Haba Laboratories is 4925.T.

How much dividend does Haba Laboratories pay?

Over the past 12 months, Haba Laboratories paid a dividend of 40 JPY . This corresponds to a dividend yield of about 2.01 %. For the coming 12 months, Haba Laboratories is expected to pay a dividend of 40 JPY.

What is the dividend yield of Haba Laboratories?

The current dividend yield of Haba Laboratories is 2.01 %.

When does Haba Laboratories pay dividends?

Haba Laboratories pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of Haba Laboratories?

Haba Laboratories paid dividends every year for the past 20 years.

What is the dividend of Haba Laboratories?

For the upcoming 12 months, dividends amounting to 40 JPY are expected. This corresponds to a dividend yield of 2.01 %.

In which sector is Haba Laboratories located?

Haba Laboratories is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Haba Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Haba Laboratories from 6/1/2024 amounting to 40 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did Haba Laboratories pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of Haba Laboratories in the year 2023?

In the year 2023, Haba Laboratories distributed 40 JPY as dividends.

In which currency does Haba Laboratories pay out the dividend?

The dividends of Haba Laboratories are distributed in JPY.

All fundamentals about Haba Laboratories

Our stock analysis for Haba Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Haba Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.